Embio Diagnostics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

Embio Diagnostics General Information

Description

Operator of a biotechnology company intended to design and develop portable, biosensor-based, and digital devices for rapid diagnostics. The company's devices can be used in the medical industry for fast detection and diagnosis, both for professional and individual use, and offer biosensor-based, multi-use handheld chemical analyzer systems for rapid diagnostics in food safety, enabling healthcare firms to help detect and monitor bacteria and viruses.

Contact Information

Formerly Known As
EMBIO
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Athalassas Avenue 8
  • Strovolos
  • Nicosia, Limassol 2018
  • Cyprus
+357
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Athalassas Avenue 8
  • Strovolos
  • Nicosia, Limassol 2018
  • Cyprus
+357

Embio Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Embio Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 26-Aug-2026 Completed Generating Revenue
5. Accelerator/Incubator 23-Apr-2026 Completed Generating Revenue
4. Angel (individual) 04-Dec-2025 Completed Generating Revenue
3. Seed Round 15-Nov-2024 Completed Generating Revenue
2. Seed Round 13-Dec-2021 $1.13M $1.13M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
To view Embio Diagnostics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Embio Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to design and develop portable, biosensor-based, and digital devices for ra
Diagnostic Equipment
Nicosia, Cyprus
30 As of 2026

Abbot Park, IL
 

Singapore, Singapore
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Embio Diagnostics Competitors (5)

One of Embio Diagnostics’s 5 competitors is Abbott, a Corporation company based in Abbot Park, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbott Corporation Abbot Park, IL
Avatamed Venture Capital-Backed Singapore, Singapore
Meteobot Corporation Varna, Bulgaria
Airthings Formerly VC-backed Oslo, Norway
Atmo (Electronics (B2C)) Corporation San Francisco, CA
You’re viewing 5 of 5 competitors. Get the full list »

Embio Diagnostics Patents

Embio Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4646593-A1 Method and system for checking and evaluation of activation of porous materials Pending 03-Mar-2023
US-20260219232-A1 Method and system for checking and evaluation of activation of porous materials Pending 03-Mar-2023
WO-2024184092-A1 Method and system for checking and evaluation of activation of porous materials Inactive 03-Mar-2023 G01N33/388

Embio Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Embio Diagnostics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plug and Play Accelerator/Incubator
European Innovation Council Accelerator/Incubator
Angel (individual) Minority
ASBISC Corporate Venture Capital Corporate Venture Capital
Kinisis Ventures Venture Capital Minority
To view Embio Diagnostics’s complete investors history, request access »

Embio Diagnostics Acquisitions (1)

Embio Diagnostics’s most recent deal was a Merger/Acquisition with Ag Catalytic Solutions. The deal was made on 26-Jun-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ag Catalytic Solutions 26-Jun-2024 Merger/Acquisition Other Commercial Products
To view Embio Diagnostics’s complete acquisitions history, request access »

Embio Diagnostics FAQs

  • When was Embio Diagnostics founded?

    Embio Diagnostics was founded in 2016.

  • Where is Embio Diagnostics headquartered?

    Embio Diagnostics is headquartered in Nicosia, Cyprus.

  • What is the size of Embio Diagnostics?

    Embio Diagnostics has 30 total employees.

  • What industry is Embio Diagnostics in?

    Embio Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Embio Diagnostics a private or public company?

    Embio Diagnostics is a Private company.

  • What is Embio Diagnostics’s current revenue?

    The current revenue for Embio Diagnostics is .

  • How much funding has Embio Diagnostics raised over time?

    Embio Diagnostics has raised $3.83M.

  • Who are Embio Diagnostics’s investors?

    Plug and Play, European Innovation Council, , ASBISC Corporate Venture Capital, and Kinisis Ventures have invested in Embio Diagnostics.

  • Who are Embio Diagnostics’s competitors?

    Abbott, Avatamed, Meteobot, Airthings, and Atmo (Electronics (B2C)) are competitors of Embio Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process